Welte K, Zeidler C, Reiter A, Riehm H
Pediatric Hematology and Oncology Medical School Hannover, Germany.
Acta Haematol Pol. 1994;25(2 Suppl 1):155-62.
In children with all types of severe neutropenia the development of G-CSF for therapeutic use changed the quality of their life dramatically. Missing the most important cells in the defense against bacterial infections the neutrophilic granulocytes, these patients suffered from episodes of severe, often life-threatening bacterial infections. They spent numerous days in hospital, requiring intravenous antibiotic treatment. Recurrence of bacterial infections at the same site led to irreversible tissue damage, for example in the lung, requiring often disabling surgical interventions. In most patients G-CSF treatment induced an increase of blood and tissue neutrophils to a level high enough to guarantee a normal defense against bacterial infections. The quality of life improved substantially in these children. The fact that they have to inject themselves daily does not cause any problems. Overall, taken in consideration all possible adverse events during our short observation period, all patients who responded to G-CSF benefit from this treatment to a degree never considered to be possible before.
在所有类型的严重中性粒细胞减少症患儿中,用于治疗的粒细胞集落刺激因子(G-CSF)的出现极大地改变了他们的生活质量。由于缺乏抵御细菌感染的最重要细胞——嗜中性粒细胞,这些患者遭受严重的、常常危及生命的细菌感染发作。他们在医院度过无数日子,需要静脉注射抗生素治疗。同一部位细菌感染的复发导致不可逆转的组织损伤,例如肺部,常常需要进行致残性的外科干预。在大多数患者中,G-CSF治疗使血液和组织中的中性粒细胞增加到足以保证正常抵御细菌感染的水平。这些儿童的生活质量有了显著改善。他们必须每天给自己注射这一事实并未造成任何问题。总体而言,考虑到我们短观察期内所有可能的不良事件,所有对G-CSF有反应的患者都从这种治疗中受益,受益程度是以前从未认为可能的。